Drug-labels.com

Isoflurane USP (Fresenius Kabi Canada): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
99.9 %
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Isoflurane USP (Fresenius Kabi Canada)

ABOUT THIS MEDICATION

What the medication is used for:

Isoflurane USP is used to put you under general anesthesia.

What it does:

Isoflurane USP is used to induce and maintain anesthesia.

When it should not be used:

Isoflurane USP should not be used if:

  • You have been told that you are allergic to isoflurane or other inhaled general anesthetics, or components of the container.
  • You have a history of liver inflammation (hepatitis) due to the use of an inhaled general anesthetic, or have experienced

    unexplained liver problems (for example jaundice with fever)

    after a previous use of an inhaled general anesthetic.

  • You or any member of your family has experienced a condition called malignant hyperthermia (a genetic disorder that causes rapid raise in body temperature) during an operation.

What the medicinal ingredient is:

Isoflurane, USP

What the nonmedicinal ingredients are:

The finished product is composed solely of the active ingredient, isoflurane, USP.

What dosage forms it comes in:

Isoflurane USP (Isoflurane, 99.9%) is available in 100 mL and 250 mL amber-colored bottles. The liquid is changed to gas in a vaporizer for inhalation. The vaporizer is designed to be used only with Isoflurane USP.

ARNINGS

WARNINGS AND PRECAUTIONS

AND PRECAUTIONS

Serious Warnings and Precautions

  • Isoflurane USP should only be administered by qualified individuals trained in general anesthesia in an adequately equipped facility.
  • Isoflurane USP may trigger a rise in blood potassium or body temperature. You may experience stiff muscles, changes in blood pressure, rapid breathing, a bluish colour to lips or fingers, rapid or irregular heart rate. Trained healthcare professionals will take care of you if this happens.

You should talk to your anesthesia professional prior to your anesthesia if you are aware of any of the following conditions:

  • You have been told that you are allergic to isoflurane or other inhaled general anesthetics, or components of the container.
  • You have previously had general anesthesia, particularly if repeated over a short period of time.
  • A doctor has difficulty placing a tube down your throat to help you breathe.
  • You are pregnant (or may be pregnant).

  • You are breast-feeding.
  • You or a member of your family suffers from malignant hyperthermia (a genetic disorder that causes rapid raise in body temperature).
  • You are suffering from any other illness, such as diabetes, severe headaches, cancer, problems with your nerves or muscles (especially muscular dystrophy), nausea, or vomiting.
  • You have or are at risk for developing Increased Intracranial Pressure (ICP). ICP is increased pressure inside the skull with general symptoms such as headache, vomiting without nausea, altered level of consciousness, back pain, and changes to your eyesight.
  • You have low blood pressure, heart, kidney, or liver problems.
  • You are taking prescription or non-prescription medications or herbal medicines.

Recovery of consciousness following Isoflurane USP administration generally occurs within minutes. Change in mood may persist for several days following administration.

Performance of activities requiring mental alertness or coordination such as operating a motor vehicle or hazardous machinery may be impaired for some time after general anesthesia. Do not drive a motor vehicle or operate hazardous machinery for at least 24 hours after having a general anesthetic.

IMPORTANT: PLEASE READ

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
After exposure to Isoflurane USP, you should contact your doctor or anesthesia provider if you have any of the following reactions:
CommonAgitation, Confusion
Chills/Shivering
Difficulty Breathing

Increased Blood Sugar:

frequent urination, thirst, and hunger

Liver Disorders:

yellow color to skin and eyes, dark urine

Muscle Pain
Nausea, Vomiting

Nervous System Disorders:

confusion, nervousness, abnormal gait, dizziness, drowsiness, intellectual function decreased

Rash
Slow, Rapid, or Irregular Heartbeat
Weakness
Uncommon

High Blood Pressure:

headache, altered vision, nausea, vomiting

Low Blood Pressure:

light-headedness, fainting, especially when getting up from a lying or sitting position

Malignant Hyperthermia:

sudden fever with stiffness, pain and weakness in your muscles

Seizure or Fits

Frequency

Unknown

Heart Attack:

chest pain, shortness of breath, heart burn, sweating, weakness, fatigue, light-headedness, nausea

Serious Drug Interactions

  • Tell your healthcare professional if you have muscular diseases (especially muscular dystrophy), and:

    • You are taking potassium, and/or
    • You have heart problems, especially irregular heart beats

Tell your doctor, nurse or pharmacist about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Drugs that may interact with Isoflurane USP include:

  • Other anesthetics, tranquillizers (e.g., benzodiazepines), narcotics (e.g., opioids), muscle relaxants (e.g., pancuronium), and nitrous oxide gas.
  • Calcium channel blockers (e.g., used to treat high blood pressure or seizures)
  • Beta blockers (e.g., used to treat high blood pressure and heart problems)
  • Monoamine Oxidase (MAO) inhibitors (e.g., used to treat depression, anxiety and migraine)
  • Isoniazid (a treatment for tuberculosis)
  • Indirect-acting sympathomimetics (amphetamines and their derivatives, psychostimulants, appetite suppressants, ephedrine and its derivatives)
  • Alcohol (chronic use before anesthesia)

  • St. John’s Wort

PROPER USE OF THIS MEDICATION

Usual Dose:

Your anesthesia provider will decide what dose of Isoflurane USP you will receive. The dose will vary depending on your age, weight, the type of anesthesia that you are having, and other factors.

Overdose:

Overdosage will be handled by the anesthesia provider.

In case of drug overdose (especially if you have accidentally come in contact with Isoflurane USP on your skin, in your eyes, by swallowing it or by breathing it in), contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

This is not a complete list of side effects. For any unexpected effects while taking Isoflurane USP, contact your doctor, anesthesia provider, or pharmacist.

HOW TO STORE IT

HOW TO S

Isoflurane USP should only be administered in an adequately equipped facility. Isoflurane USP must be kept out of reach and sight of children. It is stored between 15 °C and 30 °C.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects include headache, cough, fatigue, mood changes, and nightmare.

INTERACTIONS WITH THIS MEDICATION

IMPORTANT: PLEASE READ

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

MORE INFORMATION

If you want more information about Isoflurane USP:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/index-eng.php); the Fresenius Kabi Canada Ltd. website (fresenius-kabi.ca), or by calling 1-877-821-7724.

Fresenius Kabi Canada Ltd.

165 Galaxy Blvd, Suite 100

Toronto, ON M9W 0C8

Last revised: May 23, 2018

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02231929

Revision date stated in the text: May 23, 2018

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Isoflurane USP (Fresenius Kabi Canada)

Rx or OTC
Prescription (Rx)?
DIN 02231929
Schedule(s) PRESCRIPTION
Active ingredient(s) Isoflurane 99.9 %
Dosage form(s) Liquid
Route(s) of administration Inhalation
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N01 Anesthetics
      1. N01A Anesthetics, general
        1. N01AB Halogenated hydrocarbons, general anesthetics
          1. N01AB06 Isoflurane
Company FRESENIUS KABI CANADA LTD
Current status Marketed
Current status date September 25, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.